表紙
市場調査レポート

輸液ポンプ市場:主要企業の展望 (2015-2025年)

Infusion Pumps Market: Prospects for Leading Companies 2015-2025

発行 Visiongain Ltd 商品コード 235219
出版日 ページ情報 英文 206 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=141.49円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
輸液ポンプ市場:主要企業の展望 (2015-2025年) Infusion Pumps Market: Prospects for Leading Companies 2015-2025
出版日: 2015年10月20日 ページ情報: 英文 206 Pages
概要

当レポートでは、世界の輸液ポンプの市場について調査し、輸液ポンプの概要、発展の経緯、種類、有益性、関連法規制、世界市場全体および主要国・ポンプ区分別の収益規模の推移と予測、主要製品と市場シェア、パイプライン動向、成長推進因子・阻害因子の分析、競合技術の検証などをまとめています。

第1章 レポート概要

第2章 輸液ポンプ:イントロダクション

  • 輸液ポンプとは
  • 輸液の種類
  • ポンプの種類
  • 輸液ポンプの歴史
  • 輸液ポンプが有用となる臨床環境
  • 輸液ポンプと長所と短所
  • 輸液ポンプ市場に関する法規制
  • 日本:承認プロセスの改善

第3章 輸液ポンプ:世界市場の予測

  • 世界の医療機器市場の予測
  • 輸液ポンプ市場の定義
  • 世界の輸液ポンプ市場の実績
  • 世界の輸液ポンプ市場:売上予測
  • インスリンポンプが市場を牽引
  • 将来の市場シェアの変動
  • 市場促進因子・阻害因子

第4章 主要国市場の予測

  • 世界の輸液ポンプ市場の実績:地域別内訳
  • 国別市場の予測
  • 米国
  • EU
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
  • 日本
  • 中国
  • インド
  • ブラジル
  • 韓国
  • ロシア

第5章 インスリンポンプ市場の予測

  • イントロダクション
  • 市場の実績
  • 売上予測
  • 主要製品
  • 主要パイプライン製品
  • 市場促進因子・阻害因子

第6章 経腸栄養ポンプ市場

  • イントロダクション
  • 市場の実績
  • 売上予測
  • 主要製品
  • 主要パイプライン製品
  • 市場促進因子・阻害因子

第7章 その他の輸液ポンプ市場

  • 定義
  • 市場の実績
  • 売上予測
  • 化学療法用ポンプ
  • PCA (自己調節鎮痛) 用ポンプ
  • PCAポンプ:市場促進因子・阻害因子

第8章 競合技術の分析

  • 各種ドラッグデリバリー技術
  • 世界市場の実績
  • 世界市場の予測
  • 主なパイプライン製品

第9章 輸液ポンプ市場の定性分析

  • SWOT分析
  • ポーターのファイブフォース分析

第10章 調査インタビュー

第11章 総論

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PHA0074

A Strong Infusion pumps pipeline -Will it have a significant effect on the market?

Visiongain's brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.

Included in the report is a lengthy discussion of the strengths and weakness of the field of infusion pumps, as well as the opportunities and threats facing developers. The report includes a forecast of the global infusion pumps market through to 2025, as well as forecasts for three submarkets:

  • Insulin pumps
  • Enteral feeding pumps
  • Other pumps (a grouped category inclusive of chemotherapy pumps and PCA infusion pumps).

image1

Forecasts from 2015-2025 and other analyses show you commercial prospects

This independent, 206-page report guarantees you will remain better informed than your competition. With 128 tables and figures examining the infusion pumps market space, the report gives you a visual, one-stop breakdown of your market. In addition, this report provides analysis of competing technologies, with forecasts to 2025 for the global drug delivery technologies market and the following submarkets:

  • Oral drug delivery
  • Inhalation drug delivery
  • Injectable/implantable drug delivery
  • Transdermal drug delivery
  • Ocular drug delivery
  • Nasal drug delivery

Forecasts from 2015-2025 and other analyses show you commercial prospects

Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and Porter's Five Forces analysis), product profiles and commercial developments. Read the full transcript of one exclusive expert opinion interview from an industry specialist informing your understanding and allowing you to assess prospects for investments and sales, including:

  • Prof. Charles Clark, Former Associate Dean, Indiana University School of Medicine

Discover how high revenues can go. Our analysis also breaks the main world forecast into geographical markets.

image2

What are the prospects in the leading regions and countries?

National markets are also discussed, with forecasts to 2025 provided for the US, EU5 (Germany, UK, France, Italy and Spain), Japan, China, India, Brazil, Russia and South Korea.

There will be growth in both developed and developing pharmaceutical markets. Our analyses show that the emerging markets will achieve high revenue growth by 2025.

Potential for market growth

Overall world revenue for infusion pumps will reach $8.09bn in 2015, our work forecasts. We predict strong revenue growth through to 2025. Market entry of novel therapies, increasing conversion from conventional methods for insulin delivery to the use of insulin infusion pumps, and a shift towards homecare will drive sales until 2025.

  • Discover capabilities, progress, and commercial prospects, helping you stay ahead.
  • Research and development - assess innovation, trends and possibilities
  • What about R&D? In this report you will find analyses for a number of pipeline pumps and novel technologies.
  • Advanced infusion pumps are in great demand, allowing patients safer and more reliable treatments. Our work explains, discussing many issues.

image3

How does Infusion Pumps Market: Prospects for Leading Companies 2015-2025 report help you?

In summary, our 206 pages report gives you the following knowledge:

  • A comprehensive introduction to infusion pumps - discover everything you need to know about their use
  • Revenue forecasts to 2025 for the leading national markets
  • Review of R&D pipelines - investigate developmental trends and progress
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market
  • View an exclusive interview transcript

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the Infusion Pumps market and leading companies. You will find data, trends and predictions. Please order our report now.

Table of Contents

1. Report Overview

  • 1.1 World Infusion Pumps Market Highlights
  • 1.2 World Infusion Pumps Market Segmentation
  • 1.3 Why You Should Read This Report
  • 1.4 How This Report Delivers
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report For?
  • 1.7 Methodology
  • 1.8 Frequently Asked Questions (FAQ)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2. Introduction to Infusion Pumps

  • 2.1 What Are Infusion Pumps?
  • 2.2 Types of Infusion
  • 2.3 Types of Pumps
    • 2.3.1 Gravity Controlled Pumps
    • 2.3.2 Positive Displacement Pumps
      • 2.3.2.1 Drip Rate Pumps
      • 2.3.2.2 Volumetric Pumps
      • 2.3.2.3 Syringe Pumps
      • 2.3.2.4 Multi-Channel Pumps
      • 2.3.2.5 Ambulatory Pumps
  • 2.4 History of Infusion Pumps
  • 2.5 What Clinical Settings Will Infusion Pumps Be Useful For?
    • 2.5.1 Infusion Pumps for Diabetes
    • 2.5.2 Infusion Pumps for Chemotherapy
    • 2.5.3 Infusion Pumps for Analgesia
    • 2.5.4 Infusion Pumps for Enteral Feeding
    • 2.5.5 Other Uses for Infusion Pumps
  • 2.6 Advantages and Disadvantages of Infusion Pumps
  • 2.7 Regulation of the Infusion Pump Market
    • 2.7.1 The US Approval and Regulation System
    • 2.7.2 The EU Approval and Regulation System
      • 2.7.2.1 Expected Changes in the New EU Medical Device Regulations
      • 2.7.2.2 Post Marketing Surveillance in the EU
  • 2.8 Japan: Improved Approval Process

3. Infusion Pumps: World Market, 2015-2025

  • 3.1 World Medical Devices Market, 2015-2025
  • 3.2 Infusion Pump Market Definition
  • 3.3 World Infusion Pumps Market, 2014
  • 3.4 World Infusion Pumps Market: Sales Forecast, 2015-2025
    • 3.4.1 The Infusion Pumps Market: Sales Forecast, 2015-2019
    • 3.4.2 The Infusion Pumps Market: Sales Forecast, 2019-2025
  • 3.5 The Infusion Pumps Market: Insulin Pumps Are Market Leaders
  • 3.6 How Will Segmental Market Shares Change to 2025?
  • 3.7 World Infusion Pumps Market: Drivers and Restraints, 2015-2025
    • 3.7.1 Ageing Population and Rising Incidences of Chronic Diseases
    • 3.7.2 Advancement in Infusion Pump Technologies
    • 3.7.3 A Shift towards Home Care
    • 3.7.4 Safety Risk and Stringent Approval Process

4. Leading National Markets, 2015-2025

  • 4.1 Regional Breakdown of World Infusion Pumps Market, 2014
  • 4.2 Infusion Pumps National Market Forecast, 2015-2025
    • 4.2.1 How Will National Market Shares Change to 2025?
  • 4.3 US Infusion Pumps Market, 2014
    • 4.3.1 US Infusion Pumps Market Forecast, 2015-2025
  • 4.4 EU Infusion Pumps Market, 2014
    • 4.4.1 EU Infusion Pumps Market Forecast, 2015-2025
    • 4.4.2 How Will EU Market Shares Change to 2025?
    • 4.4.3 Germany Infusion Pumps Market Forecast, 2015-2025
    • 4.4.4 French Infusion Pumps Market Forecast, 2015-2025
    • 4.4.5 UK Infusion Pumps Market Forecast, 2015-2025
    • 4.4.6 Italian Infusion Pumps Market Forecast, 2015-2025
    • 4.4.7 Spanish Infusion Pumps Market Forecast, 2015-2025
  • 4.5 Japanese Infusion Pumps Market, 2014
    • 4.5.1 Japanese Infusion Pumps Market Forecast, 2015-2025
  • 4.6 Chinese Infusion Pumps Market, 2014
    • 4.6.1 Chinese Infusion Pumps Market Forecast, 2015-2025
    • 4.6.2 China's 12th Five-Year-Plan (2010-2015)
    • 4.6.3 New Policies Favouring Domestically-Made Medical Devices
  • 4.7 Indian Infusion Pumps Market, 2014
    • 4.7.1 Indian Infusion Pumps Market Forecast, 2015-2025
  • 4.8 Brazilian Infusion Pumps Market, 2014
    • 4.8.1 Brazilian Infusion Pumps Market Forecast, 2015-2025
  • 4.9 South Korean Infusion Pumps Market, 2014
    • 4.9.1 South Korean Infusion Pumps Market Forecast, 2015-2025
  • 4.10 Russian Infusion Pumps Market, 2014
    • 4.10.1 Russian Infusion Pumps Market Forecast, 2015-2025

5. Insulin Pumps Submarket, 2015-2025

  • 5.1 Introduction to Insulin Pumps
    • 5.1.1 Insulin in Insulin Pumps
      • 5.1.1.1 Bolus Infusion
      • 5.1.1.2 Basal Infusion
    • 5.1.2 Advantages and Disadvantages of Insulin Pumps
    • 5.1.3 Human Insulin and Analogues
  • 5.2 Insulin Infusion Pumps Submarket, 2014
    • 5.2.1 Insulin Pumps Submarket Regional Breakdown, 2014
  • 5.3 Insulin Pumps Submarket: Sales Forecast, 2015-2025
    • 5.3.1 Insulin Pumps Submarket: Sales Forecast, 2015-2019
    • 5.3.2 Insulin Pumps Submarket: Sales Forecast, 2019-2025
  • 5.4 Leading Products in Insulin Pumps Submarket, 2015
    • 5.4.1 MiniMed (Medtronic)
    • 5.4.2 OmniPod (Insulet Corporation)
    • 5.4.3 OneTouch Ping (Animas Corporation)
    • 5.4.4 Accu-Chek Spirit (Disetronic, subsidiary of Roche)
    • 5.4.5 t:Slim (Tandem Diabetes Care)
    • 5.4.6 Animas Vibe (Animas Acquired by Johnson & Johnson)
    • 5.4.7 DANA Diabecare IISG (SOOIL)
    • 5.4.8 SpringZone (D. Medical Industries)
    • 5.4.9 Cellnovo (Cellnovo)
    • 5.4.10 V-Go (Valeritas)
  • 5.5 Key Insulin Pumps Pipeline Products, 2015
    • 5.5.1 Finesse Personal Insulin Patch (Johnson & Johnson)
    • 5.5.2 SOLO MicroPump (Roche)
    • 5.5.3 JewelPump (Debiotech)
    • 5.5.4 Artificial Pancreas (Juvenile Diabetes Research Foundation)
    • 5.5.5 PaQ (CeQur)
    • 5.5.6 t:Sensor & t:Flex (Tandem Diabetes Care)
    • 5.5.7 Freehand (MedSolve Technologies)
    • 5.5.8 NanoPump (Debiotech)
    • 5.5.9 PassPort (Altea Therapeutics)
    • 5.5.10 NiliPatch (D. Medical Industries)
  • 5.6 Insulin Pumps Submarket: Drivers and Restraints, 2015-2025
    • 5.6.1 Increased Competition Drives Innovation
    • 5.6.2 Collaborating to Address Unmet Needs
    • 5.6.3 A Strong R&D Pipeline Will Drive the Market
    • 5.6.4 Diabetes Globalisation: A Rapidly Increasing Incidence
    • 5.6.5 Developed Economies: Increasing Adoption
    • 5.6.6 Reimbursement of Insulin Pumps Will Give Long-Term Economic Benefits
    • 5.6.7 More Expensive Technology Presents a Challenge When Entering Emerging Markets
    • 5.6.8 Security Risks with Insulin Pumps

6. Enteral Feeding Pumps Submarket, 2015-2025

  • 6.1 Introduction to Enteral Feeding Pumps
    • 6.1.1 Clinical Settings That May Require Enteral Feeding
    • 6.1.2 Advantages and Disadvantages of Enteral Feeding
    • 6.1.3 Delivery of Enteral Feeding
    • 6.1.3.1 Tube Placements Used in Enteral Feeding
    • 6.1.4 Enteral Feeding at Home
  • 6.2 Enteral Feeding Pumps Submarket, 2014
    • 6.2.1 Enteral Feeding Pumps Submarket Regional Breakdown, 2014
  • 6.3 Enteral Feeding Pumps Submarket: Sales Forecast, 2015-2025
    • 6.3.1 Enteral Feeding Pumps Submarket: Sales Forecast, 2015-2019
    • 6.3.2 Enteral Feeding Pumps Submarket: Sales Forecast, 2019-2025
  • 6.4 Leading Products in Enteral Feeding Pump Submarket, 2015
    • 6.4.1 Compat DualFlo Enteral Feeding Pump (Acquired by Medline)
    • 6.4.2 Sentinel Enteral Feeding Pump (ALCOR Scientific)
    • 6.4.3 EnteraLite Infinity Enteral Feeding Pump (Zevex/Moog)
    • 6.4.4 APPLIX Vision (Fresenius Kabi)
    • 6.4.5 MiniFlo (Fresenius Kabi)
    • 6.4.6 Nutricia FloCare Infinity Pump (Danone Nutricia)
    • 6.4.7 Sapphire (Q Core Medical)
    • 6.4.8 Kangaroo Joey Enteral Feeding Pump (Covidien)
    • 6.4.9 Other Notable Enteral Feeding Pumps
  • 6.5 Enteral Feeding Pumps Submarket: Drivers and Restraints, 2015-2025
    • 6.5.1 Cost-Effective, Portable and Safer Products will Drive Growth
    • 6.5.2 Growing World Geriatric Population and Prevalence of Chronic Diseases
    • 6.5.3 Increasing Demand for Homecare Solutions and Portability
    • 6.5.4 Exit of Abbott in the US Enteral Feeding Market in 2013
    • 6.5.5 Introduction of ISO's Standards for Small-Bore Connectors
    • 6.5.6 Replacement of Pumps and Sales of Disposable Feeding Sets Will Sustain Market Revenue
    • 6.5.7 Highly Competitive Market with High Barriers to Entry

7. Other Infusion Pumps Submarket, 2015-2025

  • 7.1 Other Infusion Pumps Submarket Definition
  • 7.2 Other Infusion Pumps Submarket, 2014
  • 7.3 Other Infusion Pumps Submarket: Sales Forecast, 2015-2025
  • 7.4 Chemotherapy Pumps
    • 7.4.1 Introduction to Chemotherapy Pumps
    • 7.4.2 Advantages and Disadvantages of Chemotherapy Pumps
    • 7.4.3 Leading Drugs in the Cancer Therapeutics Market, 2014
    • 7.4.4 The Chemotherapy Pumps Market, 2015
    • 7.4.5 Leading Products in Chemotherapy Pumps Market, 2015
      • 7.4.5.1 Infusor Infusion Pump (Baxter)
      • 7.4.5.2 CODMAN 3000 (Johnson & Johnson)
      • 7.4.5.3 Optima MS (Fresenius Kabi)
      • 7.4.5.4 CADD Legacy-1 (Smiths Medical)
      • 7.4.5.5 Other Notable Chemotherapy Pumps
    • 7.4.6 Chemotherapy Pumps Market: Drivers and Restraints, 2015-2025
  • 7.5 Patient Controlled Analgesia Pumps
    • 7.5.1 What Are PCA Pumps?
    • 7.5.2 Clinical Settings Where PCA Pumps Are Used
    • 7.5.3 How Does a PCA Pump Work?
    • 7.5.4 Advantages and Disadvantages of PCA Pumps
    • 7.5.5 Narcotic Drugs
    • 7.5.6 Leading Products in the PCA Pumps Market, 2015
      • 7.5.6.1 LifeCare PCA with Hospira MedNet Software (Hospira)
      • 7.5.6.2 Alaris PCA (CareFusion)
      • 7.5.6.3 Baxter PCA II (Baxter)
      • 7.5.6.4 Curlin PainSmart IOD Pain Management System (B.Braun)
      • 7.5.6.5 CADD-Solis Infusion Pump (Smiths Medical)
      • 7.5.6.6 Other Notable PCA Pumps
  • 7.6 PCA Pumps Market: Drivers and Restraints, 2015-2025

8. Competing Technology Analysis, 2015-2025

  • 8.1 Drug Delivery Technologies
    • 8.1.1 Introduction to Drug Delivery Technologies (DDT)
    • 8.1.2 Types of Technologies for Drug Delivery
      • 8.1.2.1 Sustained/Controlled Release Systems
      • 8.1.2.2 Injection
      • 8.1.2.3 Needle Free Injections
      • 8.1.2.4 Pulmonary, Buccal and Nasal Delivery
      • 8.1.2.5 Pills and Capsules
  • 8.2 World Drug Delivery Technologies Market, 2014
    • 8.2.1 Drug Delivery Technologies Market Regional Breakdown, 2014
  • 8.3 World Drug Delivery Technologies Market Forecast, 2015-2025
  • 8.4 Key Drug Delivery Pipeline Products, 2015

9. Qualitative Analysis of the Infusion Pumps Market, 2015-2025

  • 9.1 SWOT Analysis of World Infusion Pumps Market, 2015-2025
  • 9.2 Strengths
    • 9.2.1 Highly Accurate Dosing at Regular Intervals
    • 9.2.2 Improved Quality of Life and Less Hospital Visits
    • 9.2.3 Used in a Wide Range of Clinical Settings
  • 9.3 Weaknesses
    • 9.3.1 Safety Concerns Will Call For Stricter Regulation
    • 9.3.2 Discomfort May Discourage Potential Users
    • 9.3.3 Expensive Technologies May Restrain the Market
  • 9.4 Opportunities
    • 9.4.1 Emerging Economies Are Growing
    • 9.4.2 Patient Demographics
    • 9.4.3 High Demand for Technological Advancements
    • 9.4.4 Drugs Coming Off-Patent Will Help to Drive the Market
  • 9.5 Threats
    • 9.5.1 Poor Economic Conditions in Key Regions of the Market
    • 9.5.2 Cost Effectiveness May Be Difficult to Prove
    • 9.5.3 Regulatory Bodies Can Make Entry to Market Difficult
    • 9.5.4 Technological Advances in Drug Delivery May Surpass Those in Infusion
  • 9.6 Porter's Five Forces Analysis of the Infusion Pumps Market
    • 9.6.1 Competitive Market Leaders [High]
    • 9.6.2 Threat of New Entrants [Medium]
    • 9.6.3 Power of Suppliers [Medium]
    • 9.6.4 Bargaining Power of Buyers [High]
    • 9.6.5 Threat of Substitutes [Medium]

10. Research Interviews

  • 10.1 Interview with Prof. Charles Clark, Former Associate Dean at Indiana University School of Medicine
    • 10.1.1 New Glucose-Analysing Programme
    • 10.1.2 Restraints in the Chinese Insulin Pumps Market
    • 10.1.3 Market Potentials in the Insulin Pumps Market
    • 10.1.4 Opportunities for Infusion Pumps Manufacturers
    • 10.1.5 Size of the Current Chinese Insulin Pumps Market
    • 10.1.6 Challenges Facing Infusion Pumps Manufacturers in Emerging Economies
    • 10.1.7 The Future of Insulin Pumps Market?

11. Conclusions

  • 11.1 Infusion Pumps: A Growing Industry
  • 11.2 Current Look at the World Infusion Pumps Market, 2015
  • 11.3 The Global Infusion Pumps Market: Driven or Restrained?

Glossary

List of Tables

  • Table 1.1 Infusion Pumps: Leading National Markets Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 2.1 Ideal Specification of an Infusion Pump
  • Table 2.2 Specification of a Syringe Pump
  • Table 2.3 Advantages and disadvantages of syringe pumps
  • Table 2.4 Advantages and Disadvantages of Infusion Pumps
  • Table 3.1 World Medical Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 3.2 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 3.3 Market Shares (%) of Infusion Pumps by Market Segment 2014, 2019 and 2025
  • Table 4.1 Global Infusion Pumps Market: Revenue ($bn) and Market Shares (%) by Region, 2014
  • Table 4.2 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Region, 2014-2025
  • Table 4.2 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Region, 2014-2025 (Continued)
  • Table 4.3 World Infusion Pumps Market Forecast: CAGR (%) by Region in 2014-2019, 2019-2025 and 2014-2025
  • Table 4.4 Market Shares (%) of Infusion Pumps Market by Region, in 2014, 2019, and 2025
  • Table 4.5 US Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 4.6 EU Infusion Pumps Market: Revenues ($bn) and EU Market Shares (%) by Leading Countries, 2014
  • Table 4.7 EU Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 4.8 EU5 Infusion Pumps Market Forecast: CAGR (%) by Leading Countries in 2014-2019, 2019-2025 and 2014-2025
  • Table 4.9 EU Market Shares (%) of the EU Infusion Pumps Market by Leading Countries 2014, 2019, and 2025
  • Table 4.10 Germany Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 4.11 French Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 4.12 UK Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 4.13 Italian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 4.14 Spanish Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 4.15 Japanese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 4.16 Chinese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 4.17 Indian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 4.18 Brazilian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 4.19 South Korean Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 4.20 Russian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 5.1 Control of Insulin Delivery (Infusion Types and Methods)
  • Table 5.2 Advantages and Disadvantages of Insulin Pumps
  • Table 5.3 Insulin Analogues Submarket: Leading Products by Revenue ($bn) and Market Shares (%), 2014
  • Table 5.4 Insulin Pumps Submarket: Revenue ($bn) and Market Shares (%) by Region, 2014
  • Table 5.5 Insulin Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 5.8 Diabetes Prevalence (m) in Leading National Markets, 2013
  • Table 6.1 Advantages and Disadvantages of Enteral Feeding, 2015
  • Table 6.2 Types of Tubes Used in Enteral Feeding, 2015
  • Table 6.3 Enteral Feeding Pumps Submarket: Revenues ($bn) and Market Shares (%) by Region, 2014
  • Table 6.4 Enteral Feeding Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 6.5 Leading Products in the Enteral Feeding Pumps Submarket, 2015
  • Table 6.6 Other Products in the Enteral Feeding Pumps Submarket, 2015
  • Table 7.1 Other Infusion Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 7.2 Advantages and Disadvantages of Chemotherapy Pumps
  • Table 7.3 Anti-Cancer Drugs: Revenue ($bn) and Market Shares (%), 2014
  • Table 7.4 Top 10 Anti-Cancer Drugs: Key Facts
  • Table 7.5 Leading Products in the Chemotherapy Pump Market, 2015
  • Table 7.6 Advantages and Disadvantages of PCA Pumps
  • Table 7.7 Leading Products in the PCA Pumps Market, 2015
  • Table 7.8 Other Noticeable PCA Pumps
  • Table 8.1 World Drug Delivery Technologies Market: Revenue ($bn) and Market Shares (%) by Application, 2014
  • Table 8.2 World Drug Delivery Technologies Market: Revenue ($bn) and Market Shares (%) by Country, 2014
  • Table 8.3 World Drug Delivery Technologies Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Application, 2014-2025
  • Table 8.4 Key Pipeline Products for Oral Delivery, 2015
  • Table 8.5 Key Pipeline Products for Transdermal, Transmucosal, and Implantable Delivery, 2015
  • Table 8.6 Key Pipeline Products for Inhaled and Injectable Delivery, 2015
  • Table 9.1 SWOT Analysis of World Infusion Pumps Market 2015-2025
  • Table 9.2 Average Initial Costs Associated With Insulin Pump Use ($)
  • Table 9.3 Insulin Delivery Technologies: Average Annual Costs of Usage ($)
  • Table 9.4 Infusion Pumps and Related Products Recall in the US, 2007-2015

List of Figures

  • Figure 1.1 Top Five National Infusion Pumps Market by Revenue ($bn), 2015 & 2025
  • Figure 1.2 World Infusion Pumps Market Segmentation Overview, 2015
  • Figure 2.1 Revision of the Medical Devices Directives
  • Figure 3.1 World Medical Devices Market Forecast: Revenue ($bn) and AGR (%), 2014-2025
  • Figure 3.2 World Infusion Pumps Market Forecast: Revenue ($bn) and AGR (%), 2014-2025
  • Figure 3.3 World Infusion Pumps Market Forecast: Revenues ($bn) by Segment, 2015-2025
  • Figure 3.4 World Infusion Pumps Market: Market Shares (%) by Segment, 2014
  • Figure 3.5 World Infusion Pumps Market: Market Shares (%) by Segment, 2019
  • Figure 3.6 World Infusion Pumps Market: Market Shares (%) by Segment, 2025
  • Figure 3.7 World Infusion Pumps Market: Drivers and Restraints, 2015-2025
  • Figure 4.1 World Infusion Pumps Market: Revenue ($bn) by Region, 2014
  • Figure 4.2 World Infusion Pumps Market: Market Shares (%) by Region, 2014
  • Figure 4.3 World Infusion Pumps Market Forecast: Comparison between Revenue ($bn) and CAGR (%) by Region, 2014 and 2025
  • Figure 4.4 World Infusion Pumps Market Forecast: CAGR (%) by Region in 2014-2019, 2019-2025, and 2014-2025
  • Figure 4.5 World Infusion Pumps Market: Market Shares (%) by Region, 2019
  • Figure 4.6 World Infusion Pumps Market: Market Shares (%) by Region, 2025
  • Figure 4.7 US 65+ Population Forecast: Size (m), 2014-2025
  • Figure 4.8 US Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025
  • Figure 4.9 EU Infusion Pumps Market: Leading Countries by Revenue ($bn), 2014
  • Figure 4.10 EU Infusion Pumps Market: Leading Countries by Market Share (%), 2014
  • Figure 4.11 EU Infusion Pumps Market Forecast: Revenue ($bn) and AGR (%), 2014-2025
  • Figure 4.12 EU5 Infusion Pumps Market Forecast: Revenues ($bn) by Leading Countries, 2014-2025
  • Figure 4.13 EU5 Infusion Pumps Market Forecast: CAGR (%) by Leading Countries in 2014-2019, 2019-2025 and 2014-2025
  • Figure 4.14 EU Infusion Pumps Market: EU Market Shares (%) by Leading Countries, 2019
  • Figure 4.15 EU Infusion Pumps Market: EU Market Shares (%) by Leading Countries, 2025
  • Figure 4.16 Germany Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025
  • Figure 4.17 French Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025
  • Figure 4.18 UK Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025
  • Figure 4.19 Italian Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025
  • Figure 4.20 Spanish Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025
  • Figure 4.21 Japanese Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025
  • Figure 4.22 Chinese Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025
  • Figure 4.23 China's Historical Healthcare Expenditure ($bn), 2001-2010
  • Figure 4.24 Chinese Population: Aged 65 or Over (million) in 1950, 2010, and 2050
  • Figure 4.25 Indian Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025
  • Figure 4.26 Brazilian Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025
  • Figure 4.27 South Korean Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025
  • Figure 4.28 Russian Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025
  • Figure 5.1 Insulin Analogues Submarket: Revenue ($bn) by Leading Products, 2014
  • Figure 5.2 Insulin Analogues Submarket: Leading Products by Market Shares (%), 2014
  • Figure 5.3 Insulin Pumps Submarket: Revenues ($bn) by Region, 2014
  • Figure 5.4 World Infusion Pumps Market: Market Shares (%) by Submarket and Submarket Region, 2014
  • Figure 5.5 Insulin Pumps Submarket Forecast: Revenue ($bn) and AGR (%), 2014-2025
  • Table 5.6 Leading Products in the Insulin Pumps Submarket, 2015
  • Table 5.7 Key Pipeline Products for Insulin Pumps Submarket, 2015
  • Figure 5.6 Insulin Pumps Submarket: Drivers and Restraints, 2015-2025
  • Figure 5.7 Diabetes Prevalence (%) in Leading National Markets, 2013
  • Figure 6.1 Conditions That Require The Use Of Enteral Feeding Pumps, 2015
  • Figure 6.2 Enteral Feeding Pumps Submarket: Revenues ($bn) by Region, 2014
  • Figure 6.3 World Enteral Feeding Pumps Market: Market Shares (%) by Submarket and Region, 2014
  • Figure 6.4 Enteral Feeding Pumps Submarket Forecast: Revenue ($bn) and AGR (%), 2014-2025
  • Figure 6.5 Enteral Feeding Pumps Submarket: Drivers and Restraints, 2015-2025
  • Figure 7.1 Other Infusion Pumps Submarket Forecast: Revenue ($bn) and AGR (%), 2014-2025
  • Figure 7.2 Top 10 Anti-Cancer Drugs: Revenues ($bn), 2014
  • Figure 7.3 Top 10 Anti-Cancer Drugs: Market Shares (%), 2014
  • Figure 7.4 Chemotherapy Pumps World Market: Drivers and Restraints, 2015-2025
  • Figure 7.5 Routes of PCA Administration
  • Figure 7.6 PCA Pumps World Market: Drivers and Restraints, 2015-2025
  • Figure 8.1 World Drug Delivery Technologies Market: Revenues ($bn) by Application, 2014
  • Figure 8.2 World Drug Delivery Technologies Market: Market Shares (%) by Application, 2014
  • Figure 8.3 World Drug Delivery Technologies Market: Revenues ($bn) by Country, 2014
  • Figure 8.4 World Drug Delivery Technologies Market: Market Shares (%) by Country, 2014
  • Figure 8.5 World Drug Delivery Technologies Market Forecast: Revenue ($bn) and AGR (%), 2014-2025
  • Figure 8.6 World Drug Delivery Technologies Market Forecast: Revenue ($bn) by Application, 2014-2025
  • Figure 9.1 Insulin Delivery Technologies: Average Annual Costs of Usage ($)
  • Figure 9.2 World Population Aged 65+ Forecast: Population (millions) and AGR (%), 2014-2025
  • Figure 9.3 Porter's Five Forces Analysis of the Infusion Pumps Market, 2015-2025
  • Figure 11.1 Top Five National Infusion Pumps Market by Revenue ($bn), 2015 & 2025
  • Figure 11.2 Main Drivers and Restraints In The Global Infusion Pumps Market, 2015-2025

Companies Listed

  • Abbott Nutrition
  • Akas Medical
  • Alcor Scientific
  • Alkermes
  • Allied Medical
  • Altea Therapeutics
  • Amsino International
  • Animas Corporation
  • Aradigm
  • Asante
  • B. Braun
  • Baxter
  • Bayer Healthcare
  • Becton & Dickson & Co
  • Bio-Med
  • BMS
  • Boston Scientific Corporation
  • Calibra Medical
  • Cardinal Health
  • CareFusion
  • Celgene
  • Cellnovo
  • Celsus Laboratories
  • CeQur
  • CME Medical
  • Codman and Shurtleff
  • Conmed Corporation
  • Cook Medical
  • Covidien
  • D. Medical Industries
  • Danone Nutricia
  • Debiotech
  • DePuy
  • Disetronic Medical Systems
  • DreaMed Diabetes
  • Eli Lilly
  • Emco
  • Emisphere
  • Fresenius Kabi
  • GE Medical
  • Generex Biotechnology Corporation
  • Glycologic
  • Hanraj Nayyar Medical India
  • Hospira
  • IBM
  • I-Flow
  • Insulet Corporation
  • Intercell
  • Johnson and Johnson
  • Kimberly Clark Corporation
  • Medingo
  • Medsolve Technologies
  • Medtronic
  • Micrel Medical Devices
  • Mindray
  • Moog
  • NeoDevices
  • NeoMed
  • Nestle Healthcare
  • NiliMEDIX
  • Novartis
  • Noven Pharmaceuticals
  • NovoNordisk
  • Pacira Pharmaceuticals
  • Philips Medical
  • pSivida Corporation
  • Q Core Medical
  • Roche
  • Sanofi
  • Schiller
  • Smith Medical
  • SOOIL
  • Symbios Medical Products
  • Takeda
  • Tandem Diabetics Care
  • Tandem Diagnostics
  • Terumo Medical Corporation
  • Trivitron
  • Valeritas
  • Vectura
  • Vishal Surgical
  • WalkMed Inc
  • Zevex

Other Organisations Mentioned in this Report

  • Agência Nacional de Vigilância Sanitária (ANVISA)
  • American Medical Devices and Diagnostic Association (AMDD)
  • Center for Devices and Radiological Health (CDRH)
  • Centres for Medicare and Medicaid Service (CMS)
  • China Food and Drug Administration (CFDA)
  • China's National Health and Planning Commission (NHPC)
  • Chinese Ministry of Science and Technology
  • Government Accountability Office (GAO)
  • Indiana University School of Medicine
  • Japanese Ministry of Health, Labour and Welfare (MHLW)
  • Juvenile Diabetes Research Foundation
  • Medical Devices Information & Technology Assistance Centre (MDITAC)
  • Medicines and Healthcare products Regulatory Agency (MHRA)
  • National Competent Authorities (NCAs)
  • National Diabetes Education Program (NDEP)
  • National Institute for Health and Clinical Excellence (NICE)
  • National Medical Devices Authority (NMDA)
  • NHS England
  • Ningbo First Hospital
  • Roszdravnadzor
  • Sahlgrenska Academy
  • Servicio Sanitario Nazionale (SSN)
  • South Korean Ministry for Food and Drug Safety (MFDS)
  • South Korean Ministry of Health and Welfare (MOHW)
  • South Korean Ministry of Science, ICT and Future Planning (MSIP)
  • South Korean Ministry of Trade, Industry and Energy (MOTIE)
  • Único de Saúde (SUS)
  • United Nations Population Division
  • United States Food and Drug Administration (FDA)
  • US Department of Health and Human Services
  • World Bank
  • World Health Organization (WHO)
  • Zhejiang Hospital
Back to Top